Fmoc-O-allyl-L-tyrosine

Fmoc-O-allyl-L-tyrosine is an Fmoc-protected, tyrosine-derived amino acid where the phenolic hydroxyl is masked as an O-allyl ether, retaining the L-configuration at the α-carbon. The molecule combines an N-fluorenylmethoxycarbonyl (Fmoc) carbamate for orthogonal amine protection with an allyl-protected phenol that can be selectively removed under conditions compatible with peptide synthesis. The aromatic side chain provides a phenyl ring for π-interactions and a phenolic handle that can be regenerated to enable further functional group transformations such as esterification, ether formation, or conjugation. The presence of both protected functionalities makes the compound a chiral, protected amino acid intermediate suited to controlled side-chain derivatization and downstream peptide building block preparation.

1. Peptide Synthesis

Fmoc-O-allyl-L-tyrosine is applied in peptide coupling workflows where an Fmoc-protected amino group supports stepwise N-terminal deprotection and amide bond formation. The tyrosine side chain is maintained as an O-allyl ether, which helps preserve the phenolic group during repeated coupling cycles while still allowing later side-chain activation. The orthogonal protection pattern enables selective deprotection of the phenol after peptide assembly, supporting synthesis of tyrosine-containing peptides with native or modified hydroxyl functionality. The resulting peptide products can be used as research-grade substrates for biochemical assays, as scaffold components in peptidomimetic design, and as intermediates for further functionalization.

2. Side-Chain Functionalization

Fmoc-O-allyl-L-tyrosine is used for controlled tyrosine side-chain modification in chemical biology and synthetic organic chemistry, leveraging the allyl-protected phenol as a temporary protecting group. The aromatic ring and regenerated phenolic hydroxyl can participate in selective derivatization steps such as O-alkylation, O-acylation, or conversion to activated intermediates for conjugation chemistry. The allyl ether strategy supports orthogonal handling relative to the Fmoc carbamate, allowing the phenolic functionality to be introduced or transformed at a chosen stage of synthesis. Downstream products include hydroxyl-bearing peptide analogs, tyrosine-based linkers, and phenol-reactive intermediates that can be carried into larger molecular assemblies.

3. Bioconjugation Chemistry

Fmoc-O-allyl-L-tyrosine is suitable for bioconjugation-related reagent and linker construction where the tyrosine phenol serves as a reactive anchor after deprotection. The protected phenolic group can be managed during synthesis to prevent premature crosslinking, while the Fmoc group can be removed to expose the amine for peptide fragment assembly or conjugate preparation. Regenerated tyrosine hydroxyl functionality can then be used to enable coupling to electrophiles, formation of stable ether or ester linkages, or incorporation into biomolecule-targeting constructs. The compound therefore supports the preparation of conjugation-ready peptide building blocks and chemical handles used in biomolecule labeling and molecular recognition studies.

4. Peptidomimetics And SAR Studies

Fmoc-O-allyl-L-tyrosine is employed in peptidomimetic construction and structure-activity relationship studies where tyrosine side-chain chemistry is tuned to probe binding and recognition. The aromatic ring contributes to hydrophobic and π-stacking interactions, while the phenolic oxygen can be preserved, regenerated, or further modified to modulate hydrogen-bonding capacity. The Fmoc/allyl orthogonal protection enables systematic generation of analog libraries by allowing late-stage side-chain modifications without disturbing the peptide backbone assembly. The resulting tyrosine-functionalized analogs can be incorporated into SAR workflows to support comparative evaluation of molecular scaffolds and side-chain substitution patterns.

5. Process Chemistry Intermediate

Fmoc-O-allyl-L-tyrosine is relevant to process chemistry and fine chemical synthesis as a protected amino acid intermediate that aligns with scalable peptide-manufacturing strategies. The Fmoc carbamate provides a robust N-protection element for controlled deprotection cycles, while the allyl ether on the phenol offers a chemically manageable protecting-group handle that can be removed orthogonally when required. The stereochemically defined L-tyrosine framework supports consistent incorporation into peptide building blocks and minimizes ambiguity in downstream coupling and analytical characterization. The compound can be used to prepare standardized tyrosine-containing intermediates for industrial peptide synthesis, enabling reproducible downstream derivatization routes and reliable generation of tyrosine hydroxyl-bearing products.

1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

2. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells

3. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle

4. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

5. Crystal Structure of BamB from Pseudomonas aeruginosa and Functional Evaluation of Its Conserved Structural Features